On March 4, 2019 Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, reported that James Dentzer, President and Chief Executive Officer, will present at the Cowen & Company 39th Annual Healthcare Conference on Wednesday, March 13th, at 11:20 a.m. – 11:50 a.m. EST in the Berkeley room at the Marriott Copley in Boston, MA (Press release, Curis, MAR 4, 2019, View Source [SID1234533927]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the presentation will be available on the Company’s website: www.curis.com. The webcast will be archived for 90 days.